Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 39   

Articles published

SKBI 0.530 -0.030 (-5.36%)
price chart
Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Notification Letter
XI'AN, CHINA--(Marketwired - Oct 23, 2015) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that on October 20, ...
Skystar Bio-Pharmaceutical Company Receives Approval for T-Factor Animal ...
XI'AN, CHINA--(Marketwired - Oct 27, 2015) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI) (the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced receiving ...
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
Skystar Bio-Pharmaceutical Company, through its subsidiaries, engages in the research, development, production, marketing, and sale of veterinary healthcare and medical care products in the People's Republic of China.
Related articles »  
The major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI ...
John Gregory is the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 0.580 0.00 0.00% . He lately purchased 35,000 shares in the company with the transaction value amounting to approx.
Skystar Bio-Pharmaceutical Company (SKBI) Stock Market News
Skystar Bio-Pharmaceutical Company (SKBI), a China-based manufacturer and distributor of veterinary medicine said that its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2015 and June 30, 2015 will not ...
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Related articles »  
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)'s major shareholder John ...
In a document that's submitted to the U.S. SEC, it was revealed that the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 0.560 -0.020 -3.46% John Gregory, an insider in focus, made purchase via broker for 38,730 shares of the ...
Skystar Bio delisted from Nasdaq; shares off 33%
Thinly traded nano cap Skystar Bio-Pharmaceutical (NASDAQ:SKBI) drops 33% on increased volume in response to the news that it has been delisted from the Nasdaq effective today.
Morning Alert: Advaxis, Inc. (NASDAQ:ADXS), Cytokinetics, Incorporated (NASDAQ ...
Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) shares advanced 5.43% on last trading day to close the day at $0.49. Company price to sale ratio is 0.09 and has 36.42% insider ownership.
Skystar Bio-Pharmaceutical to File Financial Results for First Quarter of ...
XI'AN, CHINA--(Marketwired - May 15, 2014) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file ...
Related articles »